Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan
Journal of Infection and Public Health · 2025
DOI: 10.1016/j.jiph.2025.102705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Yu-Chien Ho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Antiviral Agents, Adenosine Monophosphate, COVID-19 Drug Treatment, Alanine. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taipei Veterans General Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Institute of…
- Institute of Emergency and Critical Care Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Förderung
- National Science and Technology Council
- Taipei Veterans General Hospital
Zitieren
APA
Ho, Y. C., Chang, M. C., Lin, W. Y., Wu, C. Y., Liu, S. Y., Chuang, C., Juan, C. H., Liu, C. J., & Lin, Y. T. (2025). Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102705
Vancouver
Ho YC, Chang MC, Lin WY, Wu CY, Liu SY, Chuang C, et al. Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102705
BibTeX
@article{Ho2025,
author = {Ho, Yu-Chien and Chang, Min-Chi and Lin, Wen-Ying and Wu, Chia-Ying and Liu, Szu-Yu and Chuang, Chien and Juan, Chih-Han and Liu, Chia-Jen and Lin, Yi-Tsung},
title = {Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan},
journal = {Journal of Infection and Public Health},
year = {2025},
doi = {10.1016/j.jiph.2025.102705}
}
EUVIMED